This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
n11	http://dx.doi.org/10.1007/
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q84916985

rdf:type

wikibase:Item

schema:description

article scientifique publié en 2012 scientific article published on 01 October 2012 wetenschappelijk artikel artículu científicu espublizáu n'ochobre de 2012 наукова стаття, опублікована в жовтні 2012

p:P577

wds:Q84916985-611E0BF5-22C0-4ABB-BA08-7D38C34DD69E

wdt:P577

2012-10-01T00:00:00Z

p:P2093

wds:Q84916985-45E71E15-7948-4249-BFB2-A7772CC4BCA9

wdt:P2093

Michael Katsimpoulas

rdfs:label

The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis

skos:prefLabel

The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis

schema:name

The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis

p:P50

wds:Q84916985-00BCE670-65AA-4DFE-92A0-62AC47916256 wds:Q84916985-06F47EA1-1CB1-4A3E-A9E8-BF1956240E9A wds:Q84916985-0815EFD7-9596-4DF5-892E-77FA8A81F044 wds:Q84916985-EA9481BA-0F77-4311-A9A5-842BA779E32A wds:Q84916985-FBA1EFB9-DE28-4AEB-9709-D2313E311BF8 wds:Q84916985-79662FFA-3010-4F17-A0C0-36A282A6E384 wds:Q84916985-8AC8D76A-34A2-4BE5-8422-F940305E4700

wdt:P50

wd:Q72735535 wd:Q88013530 wd:Q80455972 wd:Q117237270 wd:Q56894414 wd:Q117237268 wd:Q58006822

p:P1476

wds:Q84916985-51E2D50A-4C67-484D-ACA7-8D566638B256

wdt:P1476

The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis

p:P304

wds:Q84916985-8BD1A4C0-2B56-4433-A443-7CA1150CA4BD

wdt:P304

367-374

p:P31

wds:Q84916985-2D1C9732-4FE8-441C-B204-58CFDCE1B695

wdt:P31

wd:Q13442814

p:P921

wds:Q84916985-9370750A-FD9D-47E2-881F-F22C9EBAFA2C

wdt:P921

wd:Q419345

p:P698

wds:Q84916985-E201BFDC-F64E-45B1-A870-2E7F1F305E45

wdtn:P698

n12:22940777

wdt:P698

22940777

p:P1433

wds:Q84916985-790FAFAA-7C38-4C61-A43C-9683C5C710FB

wdt:P1433

wd:Q2473050

p:P433

wds:Q84916985-224C6556-91E3-4FD1-B4EB-D0D9E3E4D149

p:P478

wds:Q84916985-74BCE0E9-4609-41F6-85F4-EEC3EEE66B6A

wdt:P433

5

wdt:P478

26

p:P356

wds:Q84916985-33204C46-13E4-4629-9332-4C13ACB015C3

wdtn:P356

n11:S10557-012-6411-3

wdt:P356

10.1007/S10557-012-6411-3